Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05091034 · ClinicalTrials.gov registry record · NA
CAMP Air: Efficacy and Cost-effectiveness in Urban Adolescents
A NA study of Asthma, sponsored by Columbia University.
- Active
- Registry status
- NA
- Development phase
- 374
- Enrollment target
- 1
- Study location
NCT05091034: Active NA study of Asthma, sponsored by Columbia University.
NCT05091034 is a NA study of Asthma that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 374 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05091034, a NA study of Asthma, is active but no longer recruiting, sponsored by Columbia University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 374 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the efficacy and cost-effectiveness of Controlling Asthma Program for Adolescents (CAMP Air), an e-health intervention, among urban predominately Black and Hispanic adolescents with uncontrolled asthma. It will also examine barriers and facilitators to adoption and implementation of CAMP Air in high-schools.
Primary Outcome
This measure, which is completed by the adolescents, assesses the adolescent's level of asthma control over the past week using 5-item version. The overall score is the mean of all questions; range = 0 - 6; lower scores indicate better control.
Conditions Studied
Interventions
- BEHAVIORAL Controlling Asthma Program for Adolescents (CAMP Air)
- BEHAVIORAL Attention Control Asthma Education Intervention
Study Locations (1)
New York
- High schools in the 5 boroughs of New York City - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 374 participants |
| Start Date | 2021-11-08 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What the registry record for NCT05091034 still lists
NCT05091034 is an interventional study that assigns participants to a tested intervention. The registered 374 participants enrollment target is mid-sized for trials with a published cap, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Controlling Asthma Program for Adolescents (CAMP Air) is the first listed.
NCT05091034 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05091034 about?
NCT05091034 is a clinical study titled "CAMP Air: Efficacy and Cost-effectiveness in Urban Adolescents". This study will test the efficacy and cost-effectiveness of Controlling Asthma Program for Adolescents (CAMP Air), an e-health intervention, among urban predominately Black and Hispanic adolescents with uncontrolled asthma. It will also examine barriers and facilitators to adoption and implementatio...
What is the current status of trial NCT05091034?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 374 participants. The study started on 2021-11-08. Estimated completion is 2027-06-30.
What conditions does trial NCT05091034 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT05091034?
The interventions under investigation include: Controlling Asthma Program for Adolescents (CAMP Air) (BEHAVIORAL), Attention Control Asthma Education Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05091034?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05091034 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05091034's enrollment target sits among peer trials
374 102nd of 374 higher than 273 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI